« Back to Record
Citation APA

Lv, S., Teugels, E., Sadones, J., De Brakeleer, S., Duerinck, J., Du Four, S., Michotte, A., De Greve, J., & Neyns, B. (2012). Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab. International journal of oncology, 41(3), 1029-1035. doi:10.3892/ijo.2012.1539


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/193045

Lv, S., Teugels, E., Sadones, J., De Brakeleer, S., Duerinck, J., Du Four, S., Michotte, A., De Greve, J., & Neyns, B. (2012). Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab. International journal of oncology, 41(3), 1029-1035. doi:10.3892/ijo.2012.1539